Immunochemotherapy for Leishmania donovani Infection in Golden Hamsters: Combinatorial Action of Poly ICLC Plus L-Arginine and Sodium Stibogluconate (Stibanate®)-Reference-Cited by-同舟云学术

Immunochemotherapy for Leishmania donovani Infection in Golden Hamsters: Combinatorial Action of Poly ICLC Plus L-Arginine and Sodium Stibogluconate (Stibanate®)

Published:1999-10 Issue:10 Volume:19 Page:1103-1106
ISSN:1079-9907
Container-title:Journal of Interferon & Cytokine Research
language:en
Short-container-title:Journal of Interferon & Cytokine Research

Author:

Bhakuni Vinod¹,Kulkarni Sangeeta¹,Ali Vahab¹,Singh Ujjawal K.¹,Levy Hilton B.²,Maheshwari Radha K.³

Affiliation:

1. Division of Membrane Biology, Central Drug Research Institute, Lucknow, India.

2. National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892.

3. Center for Combat Casualty and Life Sustainment Research, Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Cell Biology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/107999099313037

Reference14 articles.

1. New developments in the chemotherapy of leishmaniasis

2. Practical progress and new drugs for changing patterns of leishmaniasis

3. Visceral leishmaniasis unresponsive to antimonial drugs I. Clinical and immunological studies

4. Visceral leishmaniasis unresponsive to antimonial drugs II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine

5. Visceral leishmaniasis in a patient with human immunodeficiency virus

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparative evaluation of efficacy of chemotherapy, immunotherapy and immunochemotherapy in visceral leishmaniasis-an experimental study;Parasitology International;2014-08

2. To investigate the therapeutic potential of immunochemotherapy with cisplatin + 78 kDa + MPL-A againstLeishmania donovaniin BALB/c mice;Parasite Immunology;2013-12-09

3. Emerging Role of Vesicular Carriers for Therapy of Visceral Leishmaniasis: Conventional versus Novel;Critical Reviews in Therapeutic Drug Carrier Systems;2010

4. Kinetoplastid Membrane Protein-11 DNA Vaccination Induces Complete Protection against Both Pentavalent Antimonial-Sensitive and -Resistant Strains ofLeishmania donovaniThat Correlates with Inducible Nitric Oxide Synthase Activity and IL-4 Generation: Evidence for Mixed Th1- and Th2-Like Responses in Visceral Leishmaniasis;The Journal of Immunology;2005-05-19

5. Combination Therapy with Indolylquinoline Derivative and Sodium Antimony Gluconate Cures Established Visceral Leishmaniasis in Hamsters;Antimicrobial Agents and Chemotherapy;2002-01